Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

Stefan Nickels(German Cancer Research Center), Thérèse Truong(Inserm), Rebecca Hein(University of Cologne), Kristen N. Stevens(Mayo Clinic in Florida), Katharina Buck(National Center for Tumor Diseases), Sabine Behrens(German Cancer Research Center), Ursula Eilber(German Cancer Research Center), Martina E. Schmidt(German Cancer Research Center), Lothar Häberle(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alina Vrieling(Radboud University Nijmegen), Mia M. Gaudet(American Cancer Society), Jonine D. Figueroa(National Cancer Institute), Nils Schoof(Karolinska Institutet), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Anja Rudolph(German Cancer Research Center), Peter A. Fasching(University of California, Los Angeles), John L. Hopper(The University of Melbourne), Enes Makalic(The University of Melbourne), Daniel F. Schmidt(The University of Melbourne), Melissa C. Southey(The University of Melbourne), Matthias W. Beckmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arif B. Ekici(Friedrich-Alexander-Universität Erlangen-Nürnberg), Olivia Fletcher(Institute of Cancer Research), Lorna J. Gibson(London School of Hygiene & Tropical Medicine), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Julian Peto(London School of Hygiene & Tropical Medicine), Manjeet K. Humphreys(University of Cambridge), Jean Wang(University of Cambridge), Emilie Cordina‐Duverger(Inserm), F. Ménégaux(Inserm), Børge G. Nordestgaard(University of Copenhagen), Stig E. Bojesen(University of Copenhagen), Charlotte Lanng(University of Copenhagen), Hoda Anton‐Culver(University of California, Irvine), Argyrios Ziogas(University of California, Irvine), Leslie Bernstein(City Of Hope National Medical Center), Christina A. Clarke(Cancer Prevention Institute of California), Hermann Brenner(German Cancer Research Center), Heiko Müller(German Cancer Research Center), Volker Arndt(German Cancer Research Center), Christa Stegmaier(Krebsregister Saarland), Hiltrud Brauch(TH Bingen University of Applied Sciences), Thomas Brüning(Institute for Prevention and Occupational Medicine), Volker Harth(Universität Hamburg), The GENICA Network(University of Bonn), Arto Mannermaa(University of Eastern Finland), Vesa Kataja(University of Eastern Finland), Veli-Matti Kosma(University of Eastern Finland), Jaana M. Hartikainen(University of Eastern Finland), kConFab(Peter MacCallum Cancer Centre), AOCS Management Group(QIMR Berghofer Medical Research Institute), Diether Lambrechts, Dominiek Smeets, Patrick Neven, Robert Paridaens, Dieter Flesch-Janys(Universität Hamburg), Nadia Obi(Universität Hamburg), Shan Wang-Gohrke(Universität Ulm), Fergus J. Couch(Mayo Clinic), Janet E. Olson(Mayo Clinic in Florida), Celine M. Vachon(Mayo Clinic in Florida), Graham G. Giles(The University of Melbourne), Gianluca Severi(The University of Melbourne), Laura Baglietto(The University of Melbourne), Kenneth Offit(Memorial Sloan Kettering Cancer Center), Esther M. John(Cancer Prevention Institute of California), Alexander Miron(Dana-Farber Cancer Institute), Irene L. Andrulis(Mount Sinai Hospital), Julia A. Knight(Mount Sinai Hospital), Gord Glendon(Mount Sinai Hospital), Anna Marie Mulligan(University Health Network), Stephen J. Chanock(National Cancer Institute), Jolanta Lissowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Jianjun Liu(Genome Institute of Singapore), Angela Cox(University of Sheffield), Helen Cramp(University of Sheffield), Dan Connley(University of Sheffield), Sabapathy P. Balasubramanian(University of Sheffield), Alison M. Dunning(University of Cambridge), Mitul Shah(University of Cambridge), Amy Trentham-Dietz(University of Wisconsin Carbone Cancer Center), Polly A. Newcomb(Fred Hutch Cancer Center), Linda Titus(Dartmouth–Hitchcock Medical Center), Kathleen M. Egan(Moffitt Cancer Center), Elizabeth K. Cahoon(National Cancer Institute), Preetha Rajaraman(National Cancer Institute), Alice J. Sigurdson(National Cancer Institute), Michele M. Doody(National Cancer Institute), Pascal Guénel(Inserm), Paul D. P. Pharoah(University of Cambridge), Marjanka K. Schmidt(German Cancer Research Center), Per Hall(National Cancer Institute), Doug F. Easton(University of Cambridge), Montserrat García‐Closas(Institute of Cancer Research), Roger L. Milne(Spanish National Cancer Research Centre), Jenny Chang‐Claude(German Cancer Research Center)
PLoS Genetics
March 27, 2013
Cited by 166Open Access
Full Text

Abstract

Various common genetic susceptibility loci have been identified for breast cancer; however, it is unclear how they combine with lifestyle/environmental risk factors to influence risk. We undertook an international collaborative study to assess gene-environment interaction for risk of breast cancer. Data from 24 studies of the Breast Cancer Association Consortium were pooled. Using up to 34,793 invasive breast cancers and 41,099 controls, we examined whether the relative risks associated with 23 single nucleotide polymorphisms were modified by 10 established environmental risk factors (age at menarche, parity, breastfeeding, body mass index, height, oral contraceptive use, menopausal hormone therapy use, alcohol consumption, cigarette smoking, physical activity) in women of European ancestry. We used logistic regression models stratified by study and adjusted for age and performed likelihood ratio tests to assess gene-environment interactions. All statistical tests were two-sided. We replicated previously reported potential interactions between LSP1-rs3817198 and parity (Pinteraction = 2.4 × 10(-6)) and between CASP8-rs17468277 and alcohol consumption (Pinteraction = 3.1 × 10(-4)). Overall, the per-allele odds ratio (95% confidence interval) for LSP1-rs3817198 was 1.08 (1.01-1.16) in nulliparous women and ranged from 1.03 (0.96-1.10) in parous women with one birth to 1.26 (1.16-1.37) in women with at least four births. For CASP8-rs17468277, the per-allele OR was 0.91 (0.85-0.98) in those with an alcohol intake of <20 g/day and 1.45 (1.14-1.85) in those who drank ≥ 20 g/day. Additionally, interaction was found between 1p11.2-rs11249433 and ever being parous (Pinteraction = 5.3 × 10(-5)), with a per-allele OR of 1.14 (1.11-1.17) in parous women and 0.98 (0.92-1.05) in nulliparous women. These data provide first strong evidence that the risk of breast cancer associated with some common genetic variants may vary with environmental risk factors.


Related Papers

No related papers found

Powered by citation graph analysis